Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Aptamer Group

Market Cap: UK£20.9m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Lobe Sciences

Market Cap: CA$11.9m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

Laboratorio Reig Jofre

Market Cap: €227.9m

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.

enGene Holdings

Market Cap: US$332.7m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Aptorum Group

Market Cap: US$12.8m

Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.

Genetic Analysis

Market Cap: €61.1m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Immunocore Holdings

Market Cap: US$1.7b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

Vistin Pharma

Market Cap: NOK 1.0b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

Insmed

Market Cap: US$28.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Valbiotis

Market Cap: €12.6m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Compugen

Market Cap: US$129.1m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Theracryf

Market Cap: UK£4.6m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Champions Oncology

Market Cap: US$88.1m

A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.

Kezar Life Sciences

Market Cap: US$27.5m

A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.

I-Mab

Market Cap: US$405.2m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Arrowhead Pharmaceuticals

Market Cap: US$4.5b

Develops medicines for the treatment of intractable diseases in the United States.

Incannex Healthcare

Market Cap: US$55.7m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

NewAmsterdam Pharma

Market Cap: US$3.2b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

CSL

Market Cap: AU$94.0b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Invivyd

Market Cap: US$222.2m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Caliway Biopharmaceuticals

Market Cap: NT$286.2b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Norda

Market Cap: NOK 415.7m

A biotechnology company, engages in the cancer diagnostic activities.

PharmAbcine

Market Cap: ₩88.0b

PharmAbcine Inc., a clinical-stage biotech company, develops human therapeutic monoclonal antibody (mAb) for the treatment of neovascular disorders, tumors, and other medically unmet diseases.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.

Mayne Pharma Group

Market Cap: AU$419.2m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Beijing Tiantan Biological Products

Market Cap: CN¥37.6b

Beijing Tiantan Biological Products Co., Ltd.

Everest Medicines

Market Cap: HK$19.4b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

SCI Pharmtech

Market Cap: NT$7.2b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

Berry GenomicsLtd

Market Cap: CN¥4.5b

A genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China.

Hangzhou Jiuyuan Genetic Biopharmaceutical

Market Cap: HK$2.8b

A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.

3D Medicines

Market Cap: HK$1.8b

A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.

Beryl Drugs

Market Cap: ₹113.6m

Manufactures and markets pharmaceutical products in India.

CSPC Pharmaceutical Group

Market Cap: HK$103.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

Hunan Er-Kang Pharmaceutical

Market Cap: CN¥7.2b

Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

Aroa Biosurgery

Market Cap: AU$239.8m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.